Purpose of Review: Along with population aging, the incidence of both heart failure (HF) and cancer is increasing. However, little is known about new-onset cancer in HF patients. This review aims at showing recent discoveries concerning this subset of patients. Recent Findings: Not only cancer and HF share similar risk factors but also HF itself can stimulate cancer development. Some cytokines produced by the failing heart induce mild inflammation promoting carcinogenesis, as it has been recently suggested by an experimental model of HF in mice. Summary: The incidence of new-onset cancer is higher in HF patients compared to the general population, and it significantly worsens their prognosis. Moreover, the management of HF patients developing new-onset cancer is challenging, especially due to the limited therapeutic options for patients affected by both cancer and HF and the higher risk of cardiotoxicity from anticancer drugs.

Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications / Cuomo, A.; Pirozzi, F.; Attanasio, U.; Franco, R.; Elia, F.; De Rosa, E.; Russo, M.; Ghigo, A.; Ameri, P.; Tocchetti, C. G.; Mercurio, V.. - In: CURRENT ONCOLOGY REPORTS. - ISSN 1523-3790. - 23:1(2021), p. 7. [10.1007/s11912-020-00990-z]

Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications

Cuomo A.;Pirozzi F.;Attanasio U.;Franco R.;Elia F.;De Rosa E.;Russo M.;Ameri P.;Tocchetti C. G.
;
Mercurio V.
2021

Abstract

Purpose of Review: Along with population aging, the incidence of both heart failure (HF) and cancer is increasing. However, little is known about new-onset cancer in HF patients. This review aims at showing recent discoveries concerning this subset of patients. Recent Findings: Not only cancer and HF share similar risk factors but also HF itself can stimulate cancer development. Some cytokines produced by the failing heart induce mild inflammation promoting carcinogenesis, as it has been recently suggested by an experimental model of HF in mice. Summary: The incidence of new-onset cancer is higher in HF patients compared to the general population, and it significantly worsens their prognosis. Moreover, the management of HF patients developing new-onset cancer is challenging, especially due to the limited therapeutic options for patients affected by both cancer and HF and the higher risk of cardiotoxicity from anticancer drugs.
2021
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications / Cuomo, A.; Pirozzi, F.; Attanasio, U.; Franco, R.; Elia, F.; De Rosa, E.; Russo, M.; Ghigo, A.; Ameri, P.; Tocchetti, C. G.; Mercurio, V.. - In: CURRENT ONCOLOGY REPORTS. - ISSN 1523-3790. - 23:1(2021), p. 7. [10.1007/s11912-020-00990-z]
File in questo prodotto:
File Dimensione Formato  
2021 Cuomo2020_Article_CancerRiskInTheHeartFailurePop.pdf

solo utenti autorizzati

Licenza: Accesso privato/ristretto
Dimensione 560.05 kB
Formato Adobe PDF
560.05 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/829973
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
social impact